C-terminal tensin-like (CTEN): a promising biomarker and target for cancer

SH Lo - The international journal of biochemistry & cell biology, 2014 - Elsevier
SH Lo
The international journal of biochemistry & cell biology, 2014Elsevier
C-terminal tensin-like (cten, also known as tensin4, TNS4) is a member of the tensin family.
Cten protein, like the other three tensin family members, localizes to focal adhesion sites but
only shares sequence homology with other tensins at its C-terminal region, which contains
the SH2 and PTB domains. Cten is abundantly expressed in normal prostate and placenta
and is down-regulated in prostate cancer. However, overexpression of cten frequently
associates with tumors derived from breast, colon, lung, stomach, skin and pancreas. A …
Abstract
C-terminal tensin-like (cten, also known as tensin4, TNS4) is a member of the tensin family. Cten protein, like the other three tensin family members, localizes to focal adhesion sites but only shares sequence homology with other tensins at its C-terminal region, which contains the SH2 and PTB domains. Cten is abundantly expressed in normal prostate and placenta and is down-regulated in prostate cancer. However, overexpression of cten frequently associates with tumors derived from breast, colon, lung, stomach, skin and pancreas. A variety of cancer-associated growth factors and cytokines induce cten expression. Up-regulated cten promotes cell motility, prolongs epidermal growth factor receptor signaling, and enhances tumorigenicity. Emerging findings suggest that cten is a promising biomarker and therapeutic target for various cancers.
Elsevier